drugset / Trial / NCT05696574
Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to compare the efficacy and the safety of vaginal misoprostol with oral misoprostol for induction of labor in nulliparous pregnant women at or beyond completed 41 weeks.
Timeline
- Start
- 2023-01-20
- Primary completion
- 2023-06-20
- Completion
- 2023-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 25 ug | Intrathecal |